Xiaonan Zhang is the Associate Professor in the Faculty of Science and Technology, University of Canberra. He now heads the Hepatitis B Virus (HBV) Group within the Centre for Research into Therapeutic Solutions. His group focuses on clinic-oriented molecular biology and translational medicine for Hepatitis B Virus.